Drug Clinical Trials:
News on drug clinical trials, articles on tests or new drugs and medication.
-
Jun 3rd, 2009
Public Citizen, a consumer protection group sent an email to FDA asking to halt its review of blood thinner drug Prasugrel because of concerns about the drug's dose. Group urges a study of lower prasugrel dose.
-
May 21st, 2009
Cancer Research UK and Cancer Research Technology (CRT) announced they will begin a phase 1 clinical trial of an anti-cancer drug from GlaxoSmithKline (GSK).
-
May 12th, 2009
The American Heart Association is calling on doctors to enroll more patients in clinical trials for catheter-based closure of patent foramen ovale (PFO), a condition caused when an opening between the two chambers of the heart fails to close at birth.
-
Apr 27th, 2009
Representatives from four international agencies, including the director of the U.S. National Toxicology Program, today signed a memorandum of cooperation that could reduce the number of animals required for consumer product safety testing worldwide.
-
Apr 27th, 2009
The European Centre for Validation of Alternative Methods's mission is the validation of alternative methods which have the potential to replace, reduce and refine animal-based tests needed for the safety assessment of chemicals that are used in many consumer products, including cosmetics.
-
Apr 23rd, 2009
An experimental agent has shown promising results in people with advanced biliary cancer, according to a multi-institutional clinical trial.
-
Apr 14th, 2009
Nanoparticles deliver life-saving drugs to the body, tablets go down easily with a film coating, and a nasal spray delivers vaccines. Behind each product is the work of a member from the University of Iowa Pharmaceuticals Development Consortium.
-
Apr 2nd, 2009
Pfizer Inc announced the discontinuation of one of its Phase 3 studies (SUN 1107) using Sutent (sunitinib malate) in advanced breast cancer.
-
Mar 31st, 2009
Researchers have found that participants in the landmark JUPITER trial who were taking a daily statin, cut the risk of blood clots in the veins, or venous thromboembolism (VTE), overall by more than 40 percent compared to those who took a placebo.
-
Mar 26th, 2009
The National Heart, Lung, and Blood Institute has stopped a clinical trial studying the benefits and safety of administering a highly concentrated form of saline solution in the ambulance (before hospital arrival) to trauma patients suffering from shock due to severe bleeding.
